TriSalus Life Sciences, Inc. (TLSI)
2.34
-2.22
(-48.68%)
USD |
NASDAQ |
May 13, 10:25
TriSalus Life Sciences Cash from Investing (Quarterly) : -0.041M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.077M |
| Perspective Therapeutics, Inc. | -109.55M |
| AVITA Medical, Inc. | -0.019M |
| Twist Bioscience Corp. | -12.71M |
| Elutia, Inc. | 79.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.484M |
| Cash from Financing (Quarterly) | 0.277M |
| Free Cash Flow | -18.93M |
| Free Cash Flow Per Share (Quarterly) | -0.0539 |
| Free Cash Flow to Equity (Quarterly) | -2.842M |
| Free Cash Flow to Firm (Quarterly) | -1.073M |
| Free Cash Flow Yield | -21.38% |